Ioannis E. Koutroubakis
Irakleion, ESYE43, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.
Journal: Journal of Crohn's & colitis
Published: September 05, 2026
Pancreatic Hyperenzymemia in Inflammatory Bowel Disease: Clinical Characterization and Outcomes from the European PANDORA Registry.
Journal: Pathophysiology : the official journal of the International Society for Pathophysiology
Published: June 03, 2026
Renal and urological complications in patients with inflammatory bowel disease.
Journal: European journal of gastroenterology & hepatology
Published: February 26, 2026
Predictors of Response to Induction Therapy with Ustekinumab in Patients with Ulcerative Colitis: Results from a National Study in Greece.
Journal: Diseases (Basel, Switzerland)
Published: January 25, 2026
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Journal: Journal of Crohn's & colitis
Published: November 03, 2025
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Journal: Journal of Crohn's & colitis
Published: November 03, 2025
Concluding a 15-year tenure as Editor-in-Chief of Annals of Gastroenterology: growth, challenges and achievements.
Journal: Annals of gastroenterology
Published: August 18, 2025
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study.
Journal: Medicina (Kaunas, Lithuania)
Published: July 10, 2025
Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study.
Journal: World journal of gastroenterology
Published: July 01, 2025
Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST Study.
Journal: United European gastroenterology journal
Published: March 24, 2025
Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study.
Journal: European journal of gastroenterology & hepatology
Published: February 27, 2025
Last Updated: 09/26/2026